Hyperfine (HYPR) Debt Ratio (2020 - 2026)

Hyperfine's (HYPR) quarterly Debt Ratio came in at 0.22 in Q1 2026, up 41393.29% on a QoQ basis from 0.0 in Q1 2023.

Hyperfine (HYPR) Debt Ratio (2020 - 2026) Analysis & Trends

Hyperfine (HYPR) has 5 years of Debt Ratio data on file, last reported at 0.22 in Q1 2026.

Quarterly Debt Ratio changed N/A year-over-year to 0.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.22 (changed N/A YoY) and the FY2021 annual result came in at 0.01, up 122.87% from the prior year.
Debt Ratio advanced to 0.22 in Q1 2026, from 0.0 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.22 in Q1 2026 to a low of 0.0 in Q3 2022.
A 3-year average of 0.04 and a median of 0.0 in 2023 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 3.37% in 2023, down 3.37% in 2023.
Tracing HYPR's Debt Ratio over 3 years: stood at 0.0 in 2022, then advanced by 27.46% to 0.0 in 2023, then surged by 41393.29% to 0.22 in 2026.
The last three Debt Ratio figures came in at 0.22 (Q1 2026), 0.0 (Q1 2023), and 0.0 (Q3 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	199.09 Bn	193.48 Bn	7.27 Bn	0.30
2	Stryker	125.99 Bn	122.51 Bn	4.50 Bn	0.31
3	Medtronic	118.00 Bn	108.78 Bn	6.41 Bn	0.30
4	Boston Scientific	72.77 Bn	72.24 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.58 Bn	47.33 Bn	1.35 Bn	0.04
6	Dexcom	34.14 Bn	32.19 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.50 Bn	31.40 Bn	2.18 Bn	0.27
8	Koninklijke Philips	25.97 Bn	22.65 Bn	4.55 Bn	0.28
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn	0.18
10	Hyperfine	89.13 Mn	44.36 Mn	1.98 Mn	0.21

Download Data